Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA: It Is in the Blood.

Current treatment options in oncology - 1 Sept 2020

Miller Emily, Schwartzberg Lee

Abstract excerpt

OPINION STATEMENT: Liquid biopsy using blood components to assess circulating tumor DNA (ctDNA) is rapidly becoming a new standard-of-care technology in many tumor types, including breast cancer, due to the potential to provide predictive and prognostic information. The minimally invasive and repeatable nature of plasma based mutational testing is appealing for patients and facilitates enhanced disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemotherapy, Adjuvant
Share to Circulating Tumor DNA
Share to Clinical Decision-Making

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Early Detection of Cancer

Share to Liquid Biopsy

Share to Progression-Free Survival

Share to Receptor, ErbB-2

Share to Receptors, Progesterone

Source

Identifiers

PMID: 32875404
DOI: 10.1007/s11864-020-00783-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Precision Medicine for Breast Cancer Utilizing Circulating Tumor DNA: It Is in the Blood.PMID 32875404Read ↗

Circulating Tumor DNA in Breast Cancer: Current and Future Applications.Semantic proximity Read ↗

The breast is yet to come: current and future utility of circulating tumour DNA in breast cancer.Semantic proximity Read ↗

Clinical application of circulating tumor DNA in breast cancer.Semantic proximity Read ↗

The applications of plasma cell-free DNA in cancer detection: Implications in the management of breast cancer patients.Semantic proximity Read ↗

Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring.Semantic proximity Read ↗

Cell‐free circulating tumour DNA as a liquid biopsy in breast cancerSemantic proximity Read ↗

Circulating Cell-Free DNA in Breast Cancer: Searching for Hidden Information towards Precision MedicineSemantic proximity Read ↗

The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring.Semantic proximity Read ↗

Circulating tumour DNA testing in metastatic breast cancer: Integration with tissue testing.Semantic proximity Read ↗

Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients.Semantic proximity Read ↗

Clinical utility of liquid biopsy in breast cancer: A systematic review.Semantic proximity Read ↗

Clinical applications of circulating tumor DNA in monitoring breast cancer drug resistance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.